Shell Asset Management Co. reduced its stake in The Clorox Company (NYSE:CLX – Free Report) by 38.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,070 shares of the company’s stock after selling 6,804 shares during the period. Shell Asset Management Co.’s holdings in Clorox were worth $1,695,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Venturi Wealth Management LLC lifted its position in Clorox by 308.5% in the first quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after purchasing an additional 145 shares during the period. Northwest Financial Advisors bought a new position in Clorox during the fourth quarter valued at about $29,000. Core Wealth Advisors Inc. acquired a new position in Clorox during the fourth quarter worth about $29,000. First United Bank & Trust bought a new stake in Clorox in the fourth quarter worth about $31,000. Finally, GoalVest Advisory LLC acquired a new stake in Clorox in the 1st quarter valued at about $31,000. 78.53% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
CLX has been the topic of several recent research reports. Evercore ISI lowered their price objective on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research note on Wednesday, May 1st. Barclays decreased their price target on shares of Clorox from $132.00 to $122.00 and set an “underweight” rating on the stock in a research report on Friday, July 19th. TD Cowen started coverage on Clorox in a research report on Tuesday. They set a “sell” rating and a $122.00 price objective for the company. Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a report on Wednesday, April 17th. Finally, Argus raised Clorox to a “hold” rating in a report on Tuesday, June 4th. Six equities research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $142.13.
Clorox Stock Up 1.1 %
CLX traded up $1.52 on Friday, reaching $134.87. 278,187 shares of the company traded hands, compared to its average volume of 1,223,790. The company has a market cap of $16.75 billion, a price-to-earnings ratio of 69.09, a PEG ratio of 1.95 and a beta of 0.39. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The stock’s 50 day moving average price is $133.73 and its 200-day moving average price is $142.70. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.14.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business had revenue of $1.81 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same period in the previous year, the company posted $1.51 EPS. Clorox’s revenue was down 5.3% on a year-over-year basis. On average, sell-side analysts expect that The Clorox Company will post 5.91 EPS for the current fiscal year.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- What is an Earnings Surprise?
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- EV Stocks and How to Profit from Them
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- Learn Technical Analysis Skills to Master the Stock Market
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.